Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Hovione Technology has secured global rights to develop and commercialize a new ultra-affordable, multi-use blister-based dry powder inhaler patented by inventor Dr. Klaus-Dieter Beller.
read more
Cambrex announced that it has completed the construction of a $24 million highly potent API (HPAPI) manufacturing facility at its site in Charles City, IA.
read more
Cambrex announced that it has opened a new 120m2 quality control (QC) laboratory at its site in Paullo, Milan, Italy.
read more
Dalton Pharma Services announced that the FDA completed a PAI inspection of its Health-Canada licensed manufacturing facility in Canada, in January 2019.
read more
STA Pharmaceutical, a subsidiary of WuXi AppTec, and Dizal Pharmaceutical have announced a strategic partnership.
read more
Thermo Fisher Scientific has entered into a definitive agreement to acquire a drug substance manufacturing site in Cork, Ireland, from GlaxoSmithKline.
read more
Teva Pharmaceutical announced the launch of a generic version of Ranexa® (ranolazine) Extended-Release Tablets, 500 mg and 1000 mg, in the U.S.
read more
Enable Injections has entered into a multi-product development agreement with Sanofi S.A.
read more
Lannett has informed the approximately 80 employees at its Cody Labs subsidiary it has decided to cease operations and close its facility in Wyoming.
read more
Concept Life Sciences has opened a new clinical and niche commercial facility to support pharmaceutical and biotechnology companies throughout the development and manufacture of API.
read more
Gilead Sciences and Nurix Therapeutics announced a collaboration to discover, develop and commercialize a pipeline of targeted protein degradation drugs for patients with cancer.
read more
Glenmark has received a CRL from the FDA for Ryaltris™ (olopatadine hydrochloride [665 mcg] and mometasone furoate [25 mcg]), Nasal Spray.
read more
Rafael Pharmaceuticals has entered into an out-licensing agreement with Ono Pharmaceutical.
read more
The FDA has issued warning letters to three repackers of API for significant violations of current good manufacturing practice (CGMP) requirements.
read more
Takeda has officially opened a new manufacturing plant at its site at Grange Castle, in Dublin, Ireland.
read more